Immutep Ltd (IMM) Price & Analysis

Compare

116 Followers

IMM Stock Chart & Stats

Day’s Range― - ―

52-Week RangeAU$0.22 - AU$0.39

Previous CloseN/A

Volume844.76K

Average Volume (3M)2.17M

Market Cap

AU$374.31M

Enterprise ValueAU$221.71M

Total Cash (Recent Filing)AU$159.26M

Total Debt (Recent Filing)AU$1.68M

Price to Earnings (P/E)―

Beta1.51

Next Earnings

Feb 19, 2026

EPS Estimate

-0.03

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.03

Shares Outstanding1,467,864,700

10 Day Avg. Volume1,932,894

30 Day Avg. Volume2,174,017

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$0.89

Price Target Upside241.10% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

Immutep Ltd News

Immutep enters reseach collaboration with GW University Cancer Center

Immutep (IMMP) announces the initiation of an investigator-initiated Phase II trial evaluating neoadjuvant eftilagimod alfa administered subcutaneously as...

6d ago

IMMP

Immutep Collaborates with GW Cancer Center on Efti Trial for Breast Cancer

The latest announcement is out from Immutep Ltd ( ($AU:IMM) ). Immutep Limited has announced a research collaboration...

6d ago

Immutep’s Phase II Trial Data on Soft Tissue Sarcoma to be Presented at CTOS 2025

Immutep Ltd ( ($AU:IMM) ) has provided an update. Immutep Limited announced that data from its EFTISARC-NEO Phase...

20d ago

Immutep Reports Increased Loss Amid Rising R&D Costs

Immutep Ltd ( ($AU:IMM) ) has provided an update. Immutep Limited reported a significant increase in its loss...

1M ago

Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating

Maxim Group analyst Jason McCarthy maintained a Buy rating on Immutep yesterday and set a price target of...

2M ago

IMMP

Immutep receives FDA feedback on clinical development of eftilagimod alfa

Immutep (IMMP) received positive and constructive feedback from the US Food and Drug Administration, regarding future clinical development...

2M ago

IMMP

Immutep Gains FDA Support for Cancer Therapy Development

Immutep Ltd ( ($AU:IMM) ) has shared an announcement. Immutep Limited has received positive feedback from the FDA...

2M ago

Immutep reports Q4 cash receipts from customers A$6,000

During the quarter, Immutep (IMMP) continued to exercise prudent cash management as it advanced its clinical trial programs...

2M ago

IMMP

Immutep Advances Oncology Trials with Promising Results

The latest update is out from Immutep Ltd ( ($AU:IMM) ). Immutep Limited has reported significant progress in...

2M ago

Immutep’s Eftilagimod Alfa Trials to be Showcased at ESMO 2025

Immutep Ltd ( ($AU:IMM) ) has shared an announcement. Immutep Limited announced that three abstracts related to its...

2M ago

JPMorgan Ceases Substantial Holding in Immutep Ltd

Immutep Ltd ( ($AU:IMM) ) has shared an announcement. Immutep Ltd has announced that JPMorgan Chase & Co....

2M ago

Immutep Ltd Reports Changes in Substantial Holdings

Immutep Ltd ( ($AU:IMM) ) just unveiled an update. Immutep Ltd has announced changes in the substantial holdings...

2M ago

Immutep Ltd Announces Quotation of New Securities on ASX

An announcement from Immutep Ltd ( ($AU:IMM) ) is now available. Immutep Ltd announced the quotation of 7,441,304...

2M ago

Immutep announces initial efficacy data from Phase I study of IMP761

Immutep (IMMP) announces initial efficacy data and continued safety data from the placebo-controlled, double-blind first-in-human Phase I study...

3M ago

IMMP

IMM FAQ

What was Immutep Ltd’s price range in the past 12 months?

Immutep Ltd lowest share price was AU$0.22 and its highest was AU$0.39 in the past 12 months.

What is Immutep Ltd’s market cap?

Immutep Ltd’s market cap is AU$374.31M.

When is Immutep Ltd’s upcoming earnings report date?

Immutep Ltd’s upcoming earnings report date is Feb 19, 2026 which is in 144 days.

How were Immutep Ltd’s earnings last quarter?

Immutep Ltd released its earnings results on Aug 29, 2025. The company reported -AU$0.028 earnings per share for the quarter, the consensus estimate of -AU$0.028 by AU$0.

Is Immutep Ltd overvalued?

According to Wall Street analysts Immutep Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Immutep Ltd pay dividends?

Immutep Ltd does not currently pay dividends.

What is Immutep Ltd’s EPS estimate?

Immutep Ltd’s EPS estimate is -0.03.

How many shares outstanding does Immutep Ltd have?

Immutep Ltd has 1,467,864,700 shares outstanding.

What happened to Immutep Ltd’s price movement after its last earnings report?

Immutep Ltd reported an EPS of -AU$0.028 in its last earnings report, expectations of -AU$0.028. Following the earnings report the stock price went down -4.082%.

Which hedge fund is a major shareholder of Immutep Ltd?

Currently, no hedge funds are holding shares in AU:IMM

Immutep Ltd Stock Smart Score

Neutral

Fundamentals

Return on Equity

-35.86%

Trailing 12-Months

Asset Growth

-23.58%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Immutep Ltd

Immutep Ltd (IMM) is a biotechnology company focused on developing immunotherapy treatments for cancer and autoimmune diseases. The company operates primarily in the healthcare and biotechnology sectors. Its core products include drug candidates based on the LAG-3 immune control mechanism, with programs in both active immunotherapy and immune modulation.

Immutep Ltd (IMM) Earnings & Revenues

Historic Earnings Reports

IMM Stock 12 Month Forecast

Average Price Target

AU$0.89

▲(241.10% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"AU$2","-1":"-AU$1","-0.25":"-AU$0.25","0.5":"AU$0.5","1.25":"AU$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.1926605522,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$1.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.8868501542,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$0.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.458715597,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.23,0.3040508117076923,0.37810162341538467,0.45215243512307696,0.5262032468307692,0.6002540585384616,0.6743048702461539,0.7483556819538462,0.8224064936615385,0.8964573053692309,0.9705081170769232,1.0445589287846155,1.1186097404923079,{"y":1.1926605522,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.23,0.28052693493846154,0.3310538698769231,0.3815808048153846,0.4321077397538462,0.4826346746923077,0.5331616096307692,0.5836885445692308,0.6342154795076923,0.6847424144461539,0.7352693493846154,0.7857962843230769,0.8363232192615384,{"y":0.8868501542,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.23,0.24759350746153846,0.26518701492307695,0.2827805223846154,0.30037402984615386,0.3179675373076923,0.33556104476923077,0.3531545522307692,0.3707480596923077,0.38834156715384616,0.4059350746153846,0.423528582076923,0.44112208953846155,{"y":0.458715597,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.31,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.335,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.395,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.275,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.32,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.365,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.345,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.31,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.26,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.24,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.26,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.23,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >